Stock market outlook for 2026: a turning point for the UK and European stocks, says UBS

UBS forecasts a recovery in European earnings in 2026, estimating average EPS growth of c.7% (versus broader analyst consensus around 10–11%) and argues equities are supported by accelerating domestic growth, robust fiscal expansion and valuation catch-up. The bank highlights UK names and themes to own—insurers and dividend-rich financials such as Aviva (11x 2026 EPS, 5.5% yield), Admiral (13x, 7.3% yield), M&G (9x, 7.5% yield), and banks including NatWest—plus thematic GOTCHA picks like RELX, Sage and ITM Power tied to productivity, AI adoption and renewables. UBS flags buybacks, positive sentiment and policy support as additional tailwinds, while warning against autos, chemicals, household goods (eg Unilever) and crowded defence exposures due to valuation and margin pressure.

Analysis

Market structure: European winners are insurers (AV., ADM, M&G), domestic banks (NWG) and data-heavy software/services (REL, SGE) where AI drives margin expansion; losers are autos, chemicals and household staples (ULVR) facing inventory/margin pressure. UBS’s 7% EPS forecast vs consensus 10–11% implies upside is valuation-driven initially — expect rotation into cyclicals only as revisions become persistent (3–12 months). A modest fiscal impulse + capex cycle will shift demand from safe-haven bonds into equities, pressuring 10y bund yields higher by 20–50bp if growth surprises.

Risk assessment: Tail risks include an ECB policy shock (hawkish surprise raising core yields >50bp in 3 months), a sharper-than-expected global slowdown (GDP <+0.5% QoQ) and EU data/privacy regulation hitting data businesses (RELX downside 20–30%). Near-term (days–weeks) moves will be driven by positioning and flows; medium-term (3–9 months) by earnings revisions and fiscal rollouts; long-term (12–36 months) by structural investment and AI adoption. Hidden dependency: AI benefit is front-loaded to firms with clean first-party data and pricing power — a regulation-driven data access shock is the primary second-order risk.

Trade implications: Favor high-yield, under-owned UK insurers and selective banks: these offer 5–8% yields plus 10–25% rerating potential over 6–12 months. Use pair trades to express conviction (long REL vs short ULVR) to isolate AI/productivity upside vs consumer elasticity risk. Options: use 3–9 month call spreads on REL/ITM to cap premium spend and buy put protection on autos/household indices to hedge a growth-sensitivity mismatch.

Contrarian angles: Consensus may underweight Europe’s domestic-led capex: a 2–3% GDP uplift from fiscal push would reignite cyclical earnings faster than currently priced. Defence and mega-cap tech may remain crowded — avoid chasing them; conversely RELX and selected insurers look underowned relative to likely 12-month EPS revision cadence. Historical parallel: 2012–14 EU recovery showed valuation-led rallies can persist before earnings catch up — position sizing and stop discipline matter.

Key Decisions for Investors

• Establish a 2.5% portfolio long position in RELX (LSE:REL) within 2 weeks, target 15–25% upside over 6–12 months (driven by 5–10% margin expansion assumptions), set a stop-loss at -12% and trim if FY26 organic revenue misses consensus by >3%.
• Allocate 2% long to Aviva (LSE:AV.) for income + re-rating: target total return 12% (5.5% yield + ~6% price) over 12 months; stop-loss -10% or if combined impairment/capital release guidance weakens CET1 by >200bp.
• Implement a pair-trade: long NatWest (LSE:NWG) 2% vs short Unilever (LSE:ULVR) 1.5% to express bank loan-growth/cost-control vs FMCG margin risk; unwind/reevaluate after Q1–Q2 2026 results or if UK consumer CPI falls >100bp year-over-year.
• Buy a 6–9 month call spread (debit) on ITM Power (AIM:ITM) sized to 0.5–1% of portfolio to play green hydrogen capex, and simultaneously purchase 3–6 month put protection on a European autos ETF (~0.5% cost) to hedge downside from inventory/margin shock.
• Reduce aggregate exposure to defence, autos and chemicals by trimming positions by 30–50% within 30 days; redeploy proceeds into selected insurers/banks/data names or cash if European 10y yields rise >40bp in a 2-week window.